A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants with Uncontrolled Hypertension

Trial Identifier: D6970C00011
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: December 2024
Study Completion Date: December 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, AZ Phoenix, AZ, US, 85018
US, AZ Tempe, AZ, US, 85281
US, CA Montclair, CA, US, 91763
US, CA Tarzana, CA, US, 91356
US, FL Tampa, FL, US, 33612
US, IL Chicago, IL, US, 60643
US, LA Metairie, LA, US, 70006
US, TX Houston, TX, US, 77074
US, TX Houston, TX, US, 77099
US, VA Norfolk, VA, US, 23502